Calithera Biosciences

Calithera Biosciences company information, Employees & Contact Information

Updated June 2026

Quick answer

Calithera Biosciences is a Pharmaceutical Manufacturing company and founded in 2010. It has approximately 27 employees on record. Contact data was last refreshed in June 2026. Find Calithera Biosciences's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Calithera Biosciences email format Calithera Biosciences management contacts

Related company profiles:

Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to preferentially starve tumor cells and enhance immune-cell activity. Driven by a commitment to rigorous science and a passion for improving the lives of people impacted by cancer and other life-threatening diseases, Calithera is advancing a pipeline of first-in-clinic, oral therapeutics to meaningfully expand treatment options available to patients.

Company Details

Employees
27
Founded
2010
Address
343 Oyster Point Blvd.,
Phone
(650) 870-1000
Email
in****@****era.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
calithera.com
HQ
South San Francisco, CA
Competitors
BridgeBio, Terns Pharmaceuticals, Para Therapeutics, RAPT Therapeutics, Arsenal Biosciences, Inc., Senti Biosciences, Novome Biotechnologies, Allogene Therapeutics, Denali Therapeutics, Achaogen.
Looking for a particular Calithera Biosciences employee's phone or email?

Calithera Biosciences Questions

News

Antengene and Calithera Biosciences Enter into Worldwide Exclusive License Agreement to Develop and Commercialize CD73 Inhibitor CB-708 (ATG-037) - PR Newswire

Antengene and Calithera Biosciences Enter into Worldwide Exclusive License Agreement to Develop and Commercialize CD73 Inhibitor CB-708 (ATG-037) PR Newswire

Cash-strapped Calithera closes down in shadow of enrollment delays to cancer trials - Fierce Biotech

Cash-strapped Calithera closes down in shadow of enrollment delays to cancer trials Fierce Biotech

Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity | Journal of Medicinal Chemistry - ACS Publications

Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity | Journal of Medicinal Chemistry ACS Publications

Calithera to suspend Phase II NSCLC trial due to lack of clinical benefit - Clinical Trials Arena

Calithera to suspend Phase II NSCLC trial due to lack of clinical benefit Clinical Trials Arena

Calithera Biosciences Initiates KEAPSAKE Randomized Phase 2 Trial of Telaglenastat in Combination with Chemoimmunotherapy to Treat Aggressive Form of Lung Cancer - Stock Titan

Calithera Biosciences Initiates KEAPSAKE Randomized Phase 2 Trial of Telaglenastat in Combination with Chemoimmunotherapy to Treat Aggressive Form of Lung Cancer Stock Titan

Calithera Biosciences Stock Nosedives On Complete Liquidation, Dissolution - Yahoo Finance

Calithera Biosciences Stock Nosedives On Complete Liquidation, Dissolution Yahoo Finance

Calithera Biosciences Scores Two Complementary Oncology Compounds in Takeda Deal - BioSpace

Calithera Biosciences Scores Two Complementary Oncology Compounds in Takeda Deal BioSpace

Biotech company Calithera plans its own death. Will others follow? - San Francisco Business Times - The Business Journals

Biotech company Calithera plans its own death. Will others follow? - San Francisco Business Times The Business Journals

Calithera flunks phase 2 cancer trial, axes 35% of staff - Fierce Biotech

Calithera flunks phase 2 cancer trial, axes 35% of staff Fierce Biotech

Why IBM, EQT, Calithera Biosciences, Amazon, and Facebook Are Trending - Insider Monkey

Why IBM, EQT, Calithera Biosciences, Amazon, and Facebook Are Trending Insider Monkey

Susan Molineaux is at it again: Weeks after biotech closes, she lands as CEO of Para Therapeutics - The Business Journals

Susan Molineaux is at it again: Weeks after biotech closes, she lands as CEO of Para Therapeutics The Business Journals

Biotech Susan Molineaux uses unique skillset to guide Calithera Biosciences - The Business Journals

Biotech Susan Molineaux uses unique skillset to guide Calithera Biosciences The Business Journals

Companies like Calithera Biosciences

Arsenal Biosciences, Inc. logo - Similar company to Calithera Biosciences

Arsenal Biosciences,...

298
Novome Biotechnologies logo - Similar company to Calithera Biosciences

Novome Biotechnologies

1
Para Therapeutics logo - Similar company to Calithera Biosciences

Para Therapeutics

7
Denali Therapeutics logo - Similar company to Calithera Biosciences

Denali Therapeutics

549
Achaogen logo - Similar company to Calithera Biosciences

Achaogen

18
Terns Pharmaceuticals logo - Similar company to Calithera Biosciences

Terns Pharmaceuticals

60
RAPT Therapeutics logo - Similar company to Calithera Biosciences

Rapt Therapeutics

142
BridgeBio logo - Similar company to Calithera Biosciences

Bridgebio

778
Senti Biosciences logo - Similar company to Calithera Biosciences

Senti Biosciences

70
Allogene Therapeutics logo - Similar company to Calithera Biosciences

Allogene Therapeutics

222

Top Calithera Biosciences Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant